All companies, by profit
508 companies and 2245 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Net profit | Quarter |
|---|---|---|---|---|---|
| 226 |
|
$95.0B | $169.22 +3.8% | $4.2B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 ICE Intercontinental Exchange |
| 227 |
|
$89.9B | $62.58 −5.4% | $4.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 FCX Freeport-McMoRan |
| 228 |
|
$163B | $231.37 −2.4% | $4.3B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 DHR Danaher |
| 229 |
|
$108B | $94.14 +1.2% | $4.4B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 SO Southern |
| 230 |
|
$69.4B | $152.74 +0.6% | $4.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 TGT Target |
| 231 |
|
$144B | $636.11 −9.2% | $4.4B Last four quarters 2027: Q1 · 2026: Q2, Q3, Q4 | Q1 FY27 STX Seagate Technology |
| 232 |
|
$141B | $558.23 +3.4% | $4.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 VRTX Vertex Pharmaceuticals |
| 233 | APP S&P 500 AppLovin Position 233 S&P 500 Share price: $232.06 −9.0% Q2 FY26 APP AppLovin | $77.7B | $232.06 −9.0% | $4.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 APP AppLovin |
| 234 |
|
$118B | $296.78 +3.7% | $4.4B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 ADP Automatic Data Processing |
| 235 |
|
$110B | $305.71 +3.1% | $4.4B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 CME CME |
| 236 |
|
$79.9B | $562.36 +0.0% | $4.5B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 NOC Northrop Grumman |
| 237 |
|
$91.5B | $342.26 +3.3% | $4.6B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 INTU Intuit |
| 238 |
|
$117B | $1,005.77 +2.5% | $4.6B Last four quarters 2027: Q1 · 2026: Q2, Q3, Q4 | Q1 FY27 MCK McKesson |
| 239 |
|
$36.0B | $133.03 +0.7% | $4.6B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 HIG Hartford |
| 240 |
|
$93.6B | $909.02 +11.0% | $4.8B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 REGN Regeneron Pharmaceuticals |
| 241 |
|
$13.3B | $111.09 +1.9% | $4.9B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 CHTR Charter Communications |
| 242 |
|
$96.1B | $77.94 −5.0% | $5.1B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 APH Amphenol |
| 243 |
|
$124B | $97.08 +0.0% | $5.2B Last four quarters 2027: Q1 · 2026: Q2, Q3, Q4 | Q1 FY27 MDT Medtronic |
| 244 |
|
$184B | $106.39 +1.7% | $6.3B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 ABT Abbott Laboratories |
| 245 |
|
$148B | $640.79 −0.4% | $6.3B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 LMT Lockheed Martin |
| 246 |
|
$524B | $296.29 +1.9% | $6.3B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 ABBV AbbVie |
| 247 |
|
$814B | $498.93 −11.9% | $6.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 AMD Advanced Micro Devices |
| 248 |
|
$79.1B | $299.30 +0.3% | $6.6B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 CI Cigna |
| 249 |
|
$118B | $209.68 +1.2% | $6.6B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 LOW Lowe's |
| 250 |
|
$86.9B | $165.64 +2.1% | $6.9B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 EOG EOG Resources |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.